Announcements Trials
Browse Landscape Eligibility

Clinical Trials

6 trials
RecentStart dateEnrollment
AGuIX × Clear all

Phase

Phase 2 2Phase 1/2 2Phase 1 2

Status

Unknown 2Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 4Thoracic 1Gynecologic 1

Conditions

Brain Neoplasms 3Gynecologic Cancer 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 3176Cyclophosphamide 3172Carboplatin 2955Radiotherapy 2771Paclitaxel 2705Gemcitabine 2549pembrolizumab 2368Bevacizumab 2192Docetaxel 2190Fluorouracil 1837Capecitabine 1815Oxaliplatin 1723Dexamethasone 1592Nivolumab 1575Doxorubicin 1500Rituximab 1480Magnetic Resonance Spectroscopy 1365Etoposide 1341Irinotecan 1240Leucovorin 1215Drug Therapy 1189Cytarabine 1126Pemetrexed 1067fludarabine 1035Specimen Handling 985Vincristine 964Prednisone 940Cetuximab 938Trastuzumab 936Lenalidomide 932

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT04789486 2025-05-23

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Dana-Farber Cancer Institute

Phase 1/2 Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04881032 2025-02-13

NANO-GBM

Centre Jean Perrin

Phase 1/2 Active not recruiting
66 enrolled
CNS

Glioblastoma

NCT03818386 2024-06-14

NANORAD2

University Hospital, Grenoble

Phase 2 Unknown
100 enrolled
CNS

Brain Neoplasms

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown
18 enrolled
Gynecologic

Gynecologic Cancer

NCT04094077 2021-06-08

NANOSTEREO

Centre Leon Berard

Phase 2 Terminated
1 enrolled
CNS

Brain Neoplasms

NCT02820454 2019-06-07

NANO-RAD

University Hospital, Grenoble

Phase 1 Completed
15 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡